Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma

Due to its cytotoxic effect in lymphoid cells, dexamethasone is widely used in the treatment of multiple myeloma (MM). However, only a subset of myeloma patients responds to high-dose dexamethasone. Despite the undeniable anti-myeloma benefits of dexamethasone, significant adverse effects have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Kervoëlen, Charlotte, Ménoret, Emmanuelle, Gomez-Bougie, Patricia, Bataille, Régis, Godon, Catherine, Marionneau-Lambot, Séverine, Moreau, Philippe, Pellat-Deceunynck, Catherine, Amiot, Martine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694963/
https://www.ncbi.nlm.nih.gov/pubmed/26323097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694963/
https://www.ncbi.nlm.nih.gov/pubmed/26323097

Ejemplares similares